These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24758513)

  • 21. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy.
    Haka AS; Shafer-Peltier KE; Fitzmaurice M; Crowe J; Dasari RR; Feld MS
    Cancer Res; 2002 Sep; 62(18):5375-80. PubMed ID: 12235010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells.
    An J; Lv J; Li A; Qiao J; Fang L; Li Z; Li B; Zhao W; Chen H; Wang L
    BMC Cancer; 2015 Jun; 15():476. PubMed ID: 26091803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
    Bambang IF; Lee YK; Richardson DR; Zhang D
    Oncogene; 2013 Mar; 32(10):1240-51. PubMed ID: 22543584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.
    Bellahcène A; Castronovo V
    Am J Pathol; 1995 Jan; 146(1):95-100. PubMed ID: 7856741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
    Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
    PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast tumors: composition of microcalcifications.
    Fandos-Morera A; Prats-Esteve M; Tura-Soteras JM; Traveria-Cros A
    Radiology; 1988 Nov; 169(2):325-7. PubMed ID: 2845471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.
    Li L; Liu C; Amato RJ; Chang JT; Du G; Li W
    Oncotarget; 2014 Nov; 5(21):10840-53. PubMed ID: 25333262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications.
    Fraser JL; Raza S; Chorny K; Connolly JL; Schnitt SJ
    Am J Surg Pathol; 1998 Dec; 22(12):1521-7. PubMed ID: 9850178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens.
    Rosenfeld I; Tartter PI; Gajdos C; Hermann G; Bleiweiss I
    Am J Surg; 2001 Jul; 182(1):1-5. PubMed ID: 11532405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of osteopontin in the formation of microcalcifications in breast cancer].
    Tókés AM; Krausz J; Kulka J; Jäckel M; Kádár A
    Orv Hetil; 2002 Aug; 143(31):1841-6. PubMed ID: 12187578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
    Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
    J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.